Literature DB >> 1750187

The histopathology of the liver in older patients with hepatitis B virus surface antigenaemia.

H Sugimura1, T Fukazawa, M Saitoh, K Nakamura, H Shimada, K Ohtsubo.   

Abstract

The histopathology of the liver and the detectability of intrahepatic hepatitis B virus (HBV) markers were studied in 34 autopsy cases in elderly patients (mean age 73.9 years, range 60-91 years) who had had a history of positive HBV surface antigenaemia prior to death. Seven of 14 persistent HBV carrier cases (group A) in which long-lasting HBV surface antigen (HBsAg) carriage in the sera had been confirmed by sequential assays, and 5 out of 15 HBV-infected people (group C, single assay) showed significant primary liver damages including chronic hepatitis, toxic hepatitis, liver cirrhosis and hepatocellular carcinoma. In 5 cases (group B), one of which was type B liver cirrhosis, HBsAg became negative and HBsAb appeared during the follow-up period (up to 33 months). Among confirmed HBV carriers, HBsAg and HBV core antigen were most frequently found in the liver of cirrhotic cases with and without hepatocellular carcinoma (5 of 6), whereas these were rarely detected in those with non-specific changes or slight hepatitic activity (1 of 7). All 5 cases in group B were negative for histological HBV-related antigens and the findings in group C were variously interpreted. Post-mortem cases of the aged HBV carriers who survived their mean life expectancy represent an important population in which to study the natural history of HBV carriers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750187     DOI: 10.1007/bf01605075

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  15 in total

1.  Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.

Authors:  T Shikata; T Uzawa; N Yoshiwara; T Akatsuka; S Yamazaki
Journal:  Jpn J Exp Med       Date:  1974-02

2.  A study of Australia-antigen-positive blood donors and their recipients, with special reference to liver histology.

Authors:  V Reinicke; E Dybkjaer; H Poulsen; O Banke; K Lylloff; E Nordenfelt
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

3.  Victoria blue-nuclear fast red stain for HBs antigen detection in paraffin section.

Authors:  K Tanaka; W Mori; K Suwa
Journal:  Acta Pathol Jpn       Date:  1981-01

4.  Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

Authors:  R P Beasley; L Y Hwang; C C Lin; C S Chien
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

Review 5.  Chronic type B hepatitis and the "healthy" HBsAg carrier state.

Authors:  J H Hoofnagle; D A Shafritz; H Popper
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

6.  Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients.

Authors:  M B Ray; V J Desmet; J Fevery; J De Groote; A F Bradburne; J Desmyter
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

7.  Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state.

Authors:  S V Feinman; B Berris; N Cooter; J C Sinclair; D M Wrobel
Journal:  Hepatogastroenterology       Date:  1982-04

8.  Distribution of HBs antigen in livers revealed by orcein staining.

Authors:  S Nakaso; M Sakurai
Journal:  Hepatogastroenterology       Date:  1982-02

Review 9.  Pathology of hepatocellular carcinoma.

Authors:  W Mori; R Machinami; K Tanaka
Journal:  Pathol Res Pract       Date:  1980       Impact factor: 3.250

10.  Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study.

Authors:  K Sakuma; T Takahara; K Okuda; F Tsuda; M Mayumi
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.